Associations of circulating and dietary vitamin D with prostate cancer risk: A systematic review and dose-response meta-analysis

Cancer Causes and Control

Volumn 22, Issue 3, 2011, Pages 319-340

  Gilbert, Rebecca ^a   Martin, Richard M ^a   Beynon, Rebecca ^a   Harris, Ross ^b   Savovic, Jelena ^a   Zuccolo, Luisa ^a   Bekkering, Geertruida E ^c,d   Fraser, William D ^e   Sterne, Jonathan A C ^a   Metcalfe, Chris ^a  

^a UNIVERSITY OF BRISTOL   (United Kingdom)

^b PUBLIC HEALTH ENGLAND   (United Kingdom)

^c UNIVERSITY OF LEUVEN   (Belgium)

^d BeSyRe Bekkering Systematic Reviews   (Belgium)

^e UNIVERSITY OF LIVERPOOL   (United Kingdom)

Author keywords

Epidemiology; Meta analysis; Prostatic neoplasms; Review; Vitamin D

Indexed keywords

25 HYDROXYVITAMIN D; CALCITRIOL;

ARTICLE; CANCER RISK; CLINICAL TRIAL; DISEASE ACTIVITY; FOOD ANALYSIS; HUMAN; META ANALYSIS; POPULATION BASED CASE CONTROL STUDY; PRIORITY JOURNAL; PROSPECTIVE STUDY; PROSTATE CANCER; RISK ASSESSMENT; SYSTEMATIC REVIEW; VITAMIN BLOOD LEVEL; VITAMIN INTAKE; VITAMIN SUPPLEMENTATION;

CASE-CONTROL STUDIES; DIET; HUMANS; MALE; ODDS RATIO; PROSPECTIVE STUDIES; PROSTATIC NEOPLASMS; RISK; VITAMIN D; VITAMINS;

EID: 79955755462     PISSN: 09575243     EISSN: 15737225     Source Type: Journal    
DOI: 10.1007/s10552-010-9706-3     Document Type: Article

References (70)

1. Cancer Research UK (2008) Commonly diagnosed cancers worldwide
2. Cancer Research UK (2008) CancerStats report Prostate Cancer- UK, Cancer Research UK
3. Office for National Statistics (2007) Cancer incidence and mortality in the United Kingdom 2002-2004. Office for National Statistics
4. Jones G, Strugnell SA, DeLuca HF (1998) Current understanding of the molecular actions of vitamin D. Physiol Rev 78(4): 1193-1231 (Pubitemid 28491953)
5. Chen TC, Holick MF (2003) Vitamin D and prostate cancer prevention and treatment. Trends Endocrinol Metabol 14(9): 423-430 (Pubitemid 37392215)
6. Gilbert R, Metcalfe C, Oliver SE et al (2009) Life course sun exposure and risk of prostate cancer: Population-based nested case-control study and meta-analysis. Int J Cancer 125(6): 1414-1423
7. Tuohimaa P, Tenkanen L, Ahonen M et al (2004) Both high and low levels of blood vitamin D are associated with a higher prostate cancer risk: A longitudinal, nested case-control study in the Nordic countries. Int J Cancer 108:104-108 (Pubitemid 37444451)
8. Schwartz GG (2005) Vitamin D and the epidemiology of prostate cancer. Semin Dial 18(4):276-289 (Pubitemid 41159577)
9. Ali MM, Vaidya V (2007) Vitamin D and cancer. J Cancer Res Ther 3(4):225-230 (Pubitemid 351264098)
10. Peehl DM, Feldman D (2003) The role of vitamin D and retinoids in controlling prostate cancer progression. Endocr Relat Cancer 10(2):131-140 (Pubitemid 36758642)
11. Young MV, Schwartz GG, Wang L et al (2004) The prostate 25- hydroxyvitamin D-1{alpha}-hydroxylase is not influenced by parathyroid hormone and calcium: Implications for prostate cancer chemoprevention by vitamin D. Carcinogenesis 25(6): 967-971 (Pubitemid 38898635)
12. Chen TC, Wang L, Whitlatch LW, Flanagan JN, Holick MF (2003) Prostatic 25-hydroxyvitamin D-1alpha-hydroxylase and its implication in prostate cancer. J Cell Biochem 88(2):315-322 (Pubitemid 36119904)
13. Giovannucci E (2005) The epidemiology of vitamin D and cancer incidence and mortality: A review (United States). Cancer Causes Control 16(2):83-95 (Pubitemid 40691207)
14. Gross MD (2005) Vitamin D and calcium in the prevention of prostate and colon cancer: New approaches for the identification of needs. J Nutr 135(2):326-331 (Pubitemid 40194501)
15. World Cancer Research Fund/American Institute for Cancer Research (2007) Food, nutrition, physical activity, and the prevention of cancer: A global perspective. AICR, Washington, DC
16. Yin L, Raum E, Haug U, Arndt V, Brenner H (2009) Metaanalysis of longitudinal studies: Serum vitamin D and prostate cancer risk. Cancer Epidemiol 33:435-445
17. Chene G, Thompson SG (1996) Methods for summarizing the risk associations of quantitative variables in epidemiologic studies in a consistent form. Am J Epidemiol 144(6):610-621 (Pubitemid 26304406)
18. Greenland S, Longnecker MP (1992) Methods for trend estimation from summarized dose-response data, with applications to meta-analysis. Am J Epidemiol 135(11):1301-1309
19. Rowlands MA, Gunnell D, Harris R, Vatten LJ, Holly JM, Martin RM (2009) Circulating insulin-like growth factor peptides and prostate cancer risk: A systematic review and meta-analysis. Int J Cancer 124(10):2416-2429
20. Harris RJ, Deeks JJ, Altman DG, Bradburn MJ, Harbord R, Sterne JAC (2008) Metan: Fixed- and random-effects meta-analysis. Stata J 8(1):3-28
21. Higgins JP, Thompson SG, Deeks JJ, Altman DG (2003) Measuring inconsistency in meta-analyses. BMJ 327(7414):557-560 (Pubitemid 37088507)
22. Key TJ, Silcocks PB, Davey GK, Appleby PN, Bishop DT (1997) A case-control study of diet and prostate cancer. Br J Cancer 76(5):678-687 (Pubitemid 27354685)
23. Vlajinac HD, Marinkovic JM, Ilic MD, Kocev NI (1997) Diet and prostate cancer: A case-control study. Eur J Cancer 33(1):101-107 (Pubitemid 27099576)
24. Deneo-Pellegrini H, De Stefani E, Ronco A, Mendilaharsu M (1999) Foods, nutrients and prostate cancer: A case-control study in Uruguay. Br J Cancer 80(3-4):591-597 (Pubitemid 29213218)
25. Chan JM, Pietinen P, Virtanen M et al (2000) Diet and prostate cancer risk in a cohort of smokers, with a specific focus on calcium and phosphorus (Finland). Cancer Causes Control 11(9): 859-867
26. Berndt SI, Carter HB, Landis PK et al (2002) Calcium intake and prostate cancer risk in a long-term aging study: The baltimore longitudinal study of aging. Urology 60(6):1118-1123 (Pubitemid 35447591)
27. Platz EA, Leitzmann MF, Hollis BW, Willett WC, Giovannucci E (2004) Plasma 1, 25-dihydroxy- and 25-hydroxyvitamin D and subsequent risk of prostate cancer. Cancer Causes Control 15(3):255-265 (Pubitemid 38988034)
28. Tavani A, Bertuccio P, Bosetti C et al (2005) Dietary intake of calcium, vitamin D, phosphorus and the risk of prostate cancer. Eur Urol 48(1):27-33 (Pubitemid 40835586)
29. Tseng M, Breslow RA, Graubard BI, Ziegler RG (2005) Dairy, calcium, and vitamin D intakes and prostate cancer risk in the national health and nutrition examination epidemiologic followup study cohort. Am J Clin Nutr 81(5):1147-1154 (Pubitemid 41724958)
30. Park SY, Murphy SP, Wilkens LR, Stram DO, Henderson BE, Kolonel LN (2007) Calcium, vitamin D, and dairy product intake and prostate cancer risk: The Multiethnic Cohort Study. Am J Epidemiol 166(11):1259-1269 (Pubitemid 350129426)
31. Ahn J, Peters U, Albanes D et al (2008) Serum vitamin D concentration and prostate cancer risk: A nested case-control study. J Natl Cancer Inst 100(11):796-804 (Pubitemid 351809669)
32. Holt SK, Kwon EM, Peters U, Ostrander EA, Stanford JL (2009) Vitamin D pathway gene variants and prostate cancer risk. Cancer Epidemiol Biomark Prev 18(6):1929-1933
33. Kristal AR, Cohen JH, Qu P, Stanford JL (2002) Associations of energy, fat, calcium, and vitamin D with prostate cancer risk. Cancer Epidemiol Biomark Prev 11(8):719-725 (Pubitemid 34851905)
34. Kristal AR, Arnold KB, Neuhouser ML et al (2010) Diet, supplement use, and prostate cancer risk: Results from the prostate cancer prevention trial. Am J Epidemiol 172(5):566-577
35. Corder EH, Guess HA, Hulka BS et al (1993) Vitamin D and prostate cancer: A prediagnostic study with stored sera. Cancer Epidemiol Biomark Prev 2(5):467-472
36. Braun MM, Helzlsouer KJ, Hollis BW, Comstock GW (1995) Prostate cancer and prediagnostic levels of serum vitamin D metabolites (Maryland, United States). Cancer Causes Control 6(3):235-239
37. Nomura AM, Stemmermann GN, Lee J et al (1998) Serum vitamin D metabolite levels and the subsequent development of prostate cancer (Hawaii, United States). Cancer Causes Control 9(4):425-432 (Pubitemid 28466695)
38. Jacobs ET, Giuliano AR, Martinez ME, Hollis BW, Reid ME, Marshall JR (2004) Plasma levels of 25-hydroxyvitamin D, 1, 25- dihydroxyvitamin D and the risk of prostate cancer. J Steroid Biochem Mol Biol 89-90(1-5):533-537 (Pubitemid 38844343)
39. Baron JA, Beach M, Wallace K et al (2005) Risk of prostate cancer in a randomized clinical trial of calcium supplementation. Cancer Epidemiol Biomark Prev 14(3):586-589 (Pubitemid 40489200)
40. Li H, Stampfer MJ, Hollis JB et al (2007) A prospective study of plasma vitamin D metabolites, vitamin D receptor polymorphisms, and prostate cancer. PLoS Med Public Libr Sci 4(3):e103
41. Faupel-Badger JM, Diaw L, Albanes D, Virtamo J, Woodson K, Tangrea JA (2007) Lack of association between serum levels of 25-Hydroxyvitamin D and the subsequent risk of prostate cancer in finnish men. Cancer Epidemiol Biomark Prev 16(12): 2784-2786 (Pubitemid 351196338)
42. Freedman DM, Looker AC, Chang SC, Graubard BI (2007) Prospective study of serum vitamin D and cancer mortality in the United States. J Natl Cancer Inst 99(21):1594-1602
43. Travis RC, Crowe FL, Allen NE et al (2009) Serum vitamin D and risk of prostate cancer in a case-control analysis nested within the European prospective investigation into cancer and nutrition (EPIC). Am J Epidemiol 169(10):1223-1232
44. Barnett CM, Nielson CM, Shannon J et al. (2010) Serum 25-OH vitamin D levels and risk of developing prostate cancer in older men. Cancer Causes and Control online
45. Park SY, Cooney RV, Wilkens LR, Murphy SP, Henderson BE, Kolonel LN (2010) Plasma 25-hydroxyvitamin D and prostate cancer risk: The multiethnic cohort. Eur J Cancer 46(5):932-936
46. Bates B, Lennox A, Swan G (2010) National diet and nutrition survey: Headline results from year 1 of the rolling programme (2008/2009). Food Standards Agency, Department of Health, London
47. Ruston D, Henderson L, Gregory J et al. (2004) The national diet and nutrition survey: Adults aged 19-64 years. Volume 4: Nutritional status (anthropometry and blood analytes), blood pressure and physical activity. TSO, London
48. Chen L, Davey SG, Evans DM et al (2009) Genetic variants in the vitamin d receptor are associated with advanced prostate cancer at diagnosis: Findings from the prostate testing for cancer and treatment study and a systematic review. Cancer Epidemiol Biomark Prev 18(11):2874-2881
49. Egger M, Schneider M, Davey SG (1998) Spurious precision? Meta-analysis of observational studies. BMJ 316(7125):140-144 (Pubitemid 28121116)
50. Bekkering GE, Harris RJ, Thomas S et al (2008) How much of the data published in observational studies of the association between diet and prostate or bladder cancer is usable for metaanalysis? Am J Epidemiol 167(9):1017-1026 (Pubitemid 351601239)
51. Ahn J, Albanes D, Peters U et al (2007) Dairy products, calcium intake, and risk of prostate cancer in the prostate, lung, colorectal, and ovarian cancer screening trial. Cancer Epidemiol Biomark Prev 16(12):2623-2630 (Pubitemid 351196317)
52. Giovannucci E, Rimm EB, Wolk A et al (1998) Calcium and fructose intake in relation to risk of prostate cancer. Cancer Res 58(3):442-447 (Pubitemid 28087404)
53. Galic J, Simunovic D (2008) Prostate disease prevalence with epidemiological and hormonal analysis in randomly selected male population in Croatia. Coll Antropol 32(4):1195-1202
54. Chan JM, Giovannucci E, Andersson SO, Yuen J, Adami HO, Wolk A (1998) Dairy products, calcium, phosphorous, vitamin D, and risk of prostate cancer (Sweden). Cancer Causes Control 9(6):559-566 (Pubitemid 29046128)
55. Rodriguez C, McCullough ML, Mondul AM et al (2003) Calcium, dairy products, and risk of prostate cancer in a prospective cohort of United States men. Cancer Epidemiol Biomark Prev 12(7):597-603 (Pubitemid 36899838)
56. Ahonen MH, Tenkanen L, Teppo L, Hakama M, Tuohimaa P (2000) Prostate cancer risk and prediagnostic serum 25-hydroxyvitamin D levels (Finland). Cancer Causes Control 11(9): 847-852
57. Gann PH, Ma J, Hennekens CH, Hollis BW, Haddad JG, Stampfer MJ (1996) Circulating vitamin D metabolites in relation to subsequent development of prostate cancer. Cancer Epidemiol Biomark Prev 5(2):121-126
58. Mikhak B, Hunter DJ, Spiegelman D, Platz EA, Hollis BW, Giovannucci E (2007) Vitamin D receptor (VDR) gene polymorphisms and haplotypes, interactions with plasma 25-hydroxyvitamin D and 1, 25-dihydroxyvitamin D, and prostate cancer risk. Prostate 67(9):911-923 (Pubitemid 46828925)
59. Tuohimaa P, Tenkanen L, Syvala H et al (2007) Interaction of factors related to the metabolic syndrome and vitamin D on risk of prostate cancer. Cancer Epidemiol Biomark Prev 16(2): 302-307 (Pubitemid 46383350)
60. Polek TC, Weigel NL (2002) Vitamin D and prostate cancer. J Androl 23(1):9-17
61. Gao X, LaValley MP, Tucker KL (2005) Prospective studies of dairy product and calcium intakes and prostate cancer risk: A meta-analysis. J Natl Cancer Inst 97(23):1768-1777 (Pubitemid 41782286)
62. Calvo MS, Whiting SJ, Barton CN (2005) Vitamin D intake: A global perspective of current status. J Nutr 135(2):310-316 (Pubitemid 40194498)
63. Rohde CM, Manatt M, Clagett-Dame M, DeLuca HF (1999) Vitamin A antagonizes the action of vitamin D in rats. J Nutr 129(12):2246-2250
64. Bodnar LM, Catov JM, Wisner KL, Klebanoff MA (2009) Racial and seasonal differences in 25-hydroxyvitamin D detected in maternal sera frozen for over 40 years. Br J Nutr 101:278-284
65. Ross LE, Coates RJ, Breen N, Uhler RJ, Potosky AL, Blackman D (2004) Prostate-specific antigen test use reported in the 2000 national health interview survey. Prev Med 38(6):732-744 (Pubitemid 38757522)
66. Weinrich S, Ellison G, Weinrich M, Ross KS, Reis-Starr C (2002) Low sun exposure and elevated serum prostate specific antigen in African American and Caucasian men. Am J Health Stud 17:148-150
67. Gross C, Stamey T, Hancock S, Feldman D (1998) Treatment of early recurrent prostate cancer with 1, 25-dihydroxyvitamin D3 (calcitriol). J Urol 159(6):2035-2039
68. Huncharek M, Muscat J, Kupelnick B (2008) Dairy products, dietary calcium and vitamin D intake as risk factors for prostate cancer: A meta-analysis of 26, 769 cases from 45 observational studies. Nutr Cancer 60(4):421-441 (Pubitemid 351918540)
69. Gupta D, Lammersfeld CA, Trukova K, Lis CG (2009) Vitamin D and prostate cancer risk: A review of the epidemiological literature. Prostate Cancer Prostatic Dis 12(3):215-226
70. Gandini S, Boniol M, Haukka J et al. (2010) Meta-analysis of observational studies of serum 25-hydroxyvitamin D levels and colorectal, breast and prostate cancer and colorectal adenoma. Int J Cancer. doi:10.1002/ijc.25439